Delivery Order SPE2DB22D2108-SPE2DB24FU3BX

Award Date 1/22/24
Potential Completion Date 1/23/24
Potential Value $53K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SHINGRIX vial kits. The contract has a ceiling value of $6,701.92 and a period of performance that runs through September 17, 2024. The contract is a Firm Fixed Price agreement and does not utilize any set-aside designations. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts by DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $1,859.40 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SHINGRIX vial kits. This contract does not have a set-aside designation and is scheduled for completion by September 4, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to deliver a wide range of critical medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SHINGRIX vial kits. The contract is a firm-fixed price delivery order with a ceiling value of $2,208.16 and a period of performance ending on September 24, 2024. The contract is not associated with any set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SHINGRIX vial kits. The delivery order has a ceiling value of $5,962.08 and is a firm fixed-price contract. The ultimate completion date for this order is September 27, 2024. This contract is not associated with any set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of SHINGRIX vial kits. The contract has a ceiling value of $46,556.73 and is a firm fixed price contract. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract does not have a set-aside designation and has a period of performance through September 9, 2024. This contract is likely part...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to supply SHINGRIX vial kits to the Defense Logistics Agency (DLA). The $2,208.16 firm-fixed price delivery order contract has a completion date of June 3, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA for a comprehensive range of pharmaceutical products and medical supplies to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SHINGRIX vial kits, with a total ceiling value of $15,363.85 and a completion date of December 16, 2024. The contract is a firm fixed-price delivery order, with no set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of SHINGRIX VIAL KITS with a ceiling value of $5,068.44 and an ultimate completion date of May 22, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on May 21, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen, a major supplier of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of SHINGRIX vial kits. The contract has a firm fixed price value of $6,434.95 and a period of performance ending on September 19, 2024. The contract is not set aside for any specific business category. AmerisourceBergen, through its Corporate Office division, will deliver the SHINGRIX vial kits to support DLA's medical supply...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,787.88, is for the procurement of SHINGRIX vial kits. It is a firm fixed price delivery order contract with a completion date of January 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB24FU3BX
    Delivery Order

This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of SHINGRIX vial kits. The contract has a ceiling value of $52,563.89 and a period of performance through January 23, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that supplies a wide range of medical products to federal government agencies, including the DLA, to support military healthcare programs. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice, valued at up to $999,999,999 and $750,000 respectively, which serve as primary vehicles for providing comprehensive pharmaceutical and medical supply support to federal healthcare beneficiaries.

Generated 5/13/25, 10:20 AM